首页 > 最新文献

Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi最新文献

英文 中文
Myocardial Revascularization in Patients with Coronary Artery Disease and Reduced Left Ventricular Ejection Fraction 冠状动脉疾病患者的心肌血运重建和左心室射血分数降低
Q4 Medicine Pub Date : 2022-09-26 DOI: 10.30702/ujcvs/22.30(03)/km042-4449
M. Kucheriava, G. Mankovsky
The aim. To evaluate the short-term and long-term outcomes of myocardial revascularization – percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) – in patients with coronary artery disease (CAD) and heart failure (HF) with reduced left ventricular ejection fraction. Materials and methods. This one-center prospective study was conducted on the basis of the Ukrainian Children’s Cardiac Center, Clinic for Adults, Kyiv, Ukraine. Analysis included 194 patients with CAD and HF with reduced left ventricular ejection fraction. The studied cohort of patients underwent myocardial revascularization: 99 (51.1%) patients through PCI and 95 (48.9%) patients through CABG during 24 months (between January 2020 and January 2022). Results and discussion. PCI and CAD were associated with a similar risk of all-cause mortality during 30-day follow-up (HR 0,95; [95% CI], 0.135-6.796; p=0.96). When analyzing the long-term results of myocardial revascularization in terms of the effect on all-cause mortality, PCI and CABG had identical results, no significant difference was observed (HR 1.05; [95% CI], 0.448-2.481; p = 0.903). However, PCI was associated with an increased risk of repeated myocardial revascularization (HR 3.00; [95% CI], 1.251-7.221; p=0.025) compared with CABG. Patients who underwent CABG had a significant difference in the number of re-hospitalizations due to HF progression compared to those after PCI (HR 0.33; [95% CI], 0.170-0.652; p=0.002). The rehabilitation period was 2±4 days in patients after PCI, and 7±4 days in patients after CABG, which corresponded to a statistically significant difference (HR 3.48; [95% CI], 2.489-4.891; p <0.001). The visual analog scale scores of pain intensity were 3±1 in patients after PCI and 7±2 in those after CABG, the difference is statistically significant (HR 3.16; [95% CI], 2.283-4.382; p <0.001). Conclusions. Results of myocardial revascularization with PCI and CABG had identical short-term and long-term all-cause mortality rates. However, PCI was associated with a higher risk of repeated myocardial revascularization over a 2-year follow-up period. CABG, in turn, was associated with more frequent HF readmissions than PCI. The rehabilitation period was statistically shorter in patients after PCI. According to the visual analog scale, the pain in patients after CABG was more pronounced.
目标。评估左心室射血分数降低的冠状动脉疾病(CAD)和心力衰竭(HF)患者心肌血运重建(经皮冠状动脉介入治疗(PCI)和冠状动脉旁路移植术(CABG))的短期和长期结果。材料和方法。这项单中心前瞻性研究是在乌克兰基辅成人诊所乌克兰儿童心脏中心的基础上进行的。分析包括194例左心室射血分数降低的CAD和HF患者。研究的患者队列接受了心肌血运重建:在24个月内(2020年1月至2022年1月),99名(51.1%)患者通过PCI,95名(48.9%)患者通过CABG。结果和讨论。在30天的随访中,PCI和CAD与相似的全因死亡率风险相关(HR 0.95;[95%CI],0.135-6.796;p=0.96)。在分析心肌血运重建对全因死亡率影响的长期结果时,PCI和CABG的结果相同,没有观察到显著差异(HR 1.05;[95%CI],0.448-2.481;p=0.903)。然而,与冠状动脉旁路移植术相比,经皮冠状动脉介入治疗与重复心肌血运重建的风险增加相关(HR 3.00;[95%CI],1.251-7.221;p=0.025)。与PCI后相比,接受CABG的患者因HF进展而再次住院的次数有显著差异(HR 0.33;[95%CI],0.170-0.652;p=0.002)。PCI后患者的康复期为2±4天,CABG后患者的恢复期为7±4天,与统计学显著性差异相对应(HR 3.48;[95%CI],2.489-4.891;p<0.001)。PCI后患者的疼痛强度视觉模拟量表评分为3±1,CABG后患者为7±2,差异具有统计学显著性(HR 3.16;[95%CI],2.283-4.382;p<001)。结论。经皮冠状动脉介入治疗和冠状动脉搭桥术的心肌血运重建结果具有相同的短期和长期全因死亡率。然而,PCI与2年随访期内重复心肌血运重建的风险较高相关。冠状动脉旁路移植术与经皮冠状动脉介入治疗相比,HF再次入院的频率更高。PCI后患者的康复期在统计学上更短。根据视觉模拟量表,CABG后患者的疼痛更为明显。
{"title":"Myocardial Revascularization in Patients with Coronary Artery Disease and Reduced Left Ventricular Ejection Fraction","authors":"M. Kucheriava, G. Mankovsky","doi":"10.30702/ujcvs/22.30(03)/km042-4449","DOIUrl":"https://doi.org/10.30702/ujcvs/22.30(03)/km042-4449","url":null,"abstract":"The aim. To evaluate the short-term and long-term outcomes of myocardial revascularization – percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) – in patients with coronary artery disease (CAD) and heart failure (HF) with reduced left ventricular ejection fraction. \u0000Materials and methods. This one-center prospective study was conducted on the basis of the Ukrainian Children’s Cardiac Center, Clinic for Adults, Kyiv, Ukraine. Analysis included 194 patients with CAD and HF with reduced left ventricular ejection fraction. The studied cohort of patients underwent myocardial revascularization: 99 (51.1%) patients through PCI and 95 (48.9%) patients through CABG during 24 months (between January 2020 and January 2022). \u0000Results and discussion. PCI and CAD were associated with a similar risk of all-cause mortality during 30-day follow-up (HR 0,95; [95% CI], 0.135-6.796; p=0.96). When analyzing the long-term results of myocardial revascularization in terms of the effect on all-cause mortality, PCI and CABG had identical results, no significant difference was observed (HR 1.05; [95% CI], 0.448-2.481; p = 0.903). However, PCI was associated with an increased risk of repeated myocardial revascularization (HR 3.00; [95% CI], 1.251-7.221; p=0.025) compared with CABG. Patients who underwent CABG had a significant difference in the number of re-hospitalizations due to HF progression compared to those after PCI (HR 0.33; [95% CI], 0.170-0.652; p=0.002). The rehabilitation period was 2±4 days in patients after PCI, and 7±4 days in patients after CABG, which corresponded to a statistically significant difference (HR 3.48; [95% CI], 2.489-4.891; p <0.001). The visual analog scale scores of pain intensity were 3±1 in patients after PCI and 7±2 in those after CABG, the difference is statistically significant (HR 3.16; [95% CI], 2.283-4.382; p <0.001). \u0000Conclusions. Results of myocardial revascularization with PCI and CABG had identical short-term and long-term all-cause mortality rates. However, PCI was associated with a higher risk of repeated myocardial revascularization over a 2-year follow-up period. CABG, in turn, was associated with more frequent HF readmissions than PCI. The rehabilitation period was statistically shorter in patients after PCI. According to the visual analog scale, the pain in patients after CABG was more pronounced.","PeriodicalId":33680,"journal":{"name":"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46425150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tactics of Surgical Treatment of Postinfarction Ventricular Septum Rupture Depending on the Time after the Development of an Acute Myocardial Infarction 梗死后室间隔破裂的外科治疗策略与急性心肌梗死发生后时间的关系
Q4 Medicine Pub Date : 2022-09-26 DOI: 10.30702/ujcvs/22.30(03)/al035-1521
Ramil A. Aliyev, Y. Lebedieva, M. Grusha, Mykyta M. Brianskyi
The article is dedicated to topical issues of the tactics of surgical treatment of postinfarction ventricular septum rupture (PIVSR). Based on the study of the peculiarities of surgical treatment of ventricular septal defect in patients with different deadlines for surgical intervention after the development of acute myocardial infarction (AMI), the most appropriate approach to the correction of PIVSR in such patients was determined. In particular, taking into account mortality risk (42 %), the most reasonable is the use of wait-and-see tactics in the management of patients with PIVSR at the early stages after the development of AMI. At the same time, the decision on the timing of surgical intervention should be made individually, taking into account the clinical condition of the patient and the course of the postinfarction heart remodeling. Special attention is paid to the analysis of the effectiveness of the use of intra-aortic balloon counterpulsation and the time intervals of surgical intervention from the moment of hospitalization in patients with PIVSR. It was found that clinical course of coronary heart disease complicated by PIVSR can be extremely unpredictable not only in the early postinfarction period, but also up to 2 months after the development of AMI. In addition, when planning the amount of surgical intervention, it is necessary to take into account the presence of multivessel atherosclerotic lesions of the coronary arteries in patients with PIVSR, regardless of the timing after the development of AMI.
文章是专门的局部问题的策略手术治疗梗死后室间隔破裂(PIVSR)。通过对急性心肌梗死(AMI)发生后不同手术干预时限患者室间隔缺损的手术治疗特点的研究,确定此类患者最合适的PIVSR矫正方法。特别是,考虑到死亡风险(42%),在AMI发生后的早期阶段,PIVSR患者的管理中最合理的是使用观望策略。同时,应结合患者的临床情况和梗死后心脏重构的进程,单独决定手术干预的时机。特别注意分析了PIVSR患者从住院开始使用主动脉内球囊反搏的有效性和手术干预的时间间隔。研究发现,冠心病合并PIVSR的临床病程不仅在梗死后早期,甚至在AMI发生后2个月也具有极大的不可预测性。此外,在计划手术干预的数量时,必须考虑PIVSR患者冠状动脉是否存在多支动脉粥样硬化病变,而不管发生AMI后的时间。
{"title":"Tactics of Surgical Treatment of Postinfarction Ventricular Septum Rupture Depending on the Time after the Development of an Acute Myocardial Infarction","authors":"Ramil A. Aliyev, Y. Lebedieva, M. Grusha, Mykyta M. Brianskyi","doi":"10.30702/ujcvs/22.30(03)/al035-1521","DOIUrl":"https://doi.org/10.30702/ujcvs/22.30(03)/al035-1521","url":null,"abstract":"The article is dedicated to topical issues of the tactics of surgical treatment of postinfarction ventricular septum rupture (PIVSR). Based on the study of the peculiarities of surgical treatment of ventricular septal defect in patients with different deadlines for surgical intervention after the development of acute myocardial infarction (AMI), the most appropriate approach to the correction of PIVSR in such patients was determined. In particular, taking into account mortality risk (42 %), the most reasonable is the use of wait-and-see tactics in the management of patients with PIVSR at the early stages after the development of AMI. At the same time, the decision on the timing of surgical intervention should be made individually, taking into account the clinical condition of the patient and the course of the postinfarction heart remodeling. Special attention is paid to the analysis of the effectiveness of the use of intra-aortic balloon counterpulsation and the time intervals of surgical intervention from the moment of hospitalization in patients with PIVSR. It was found that clinical course of coronary heart disease complicated by PIVSR can be extremely unpredictable not only in the early postinfarction period, but also up to 2 months after the development of AMI. In addition, when planning the amount of surgical intervention, it is necessary to take into account the presence of multivessel atherosclerotic lesions of the coronary arteries in patients with PIVSR, regardless of the timing after the development of AMI.","PeriodicalId":33680,"journal":{"name":"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43856984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complete Reconstruction of the Left Heart with Atriomegaly and Ventriculomegaly: Clinical Case 左心房室肿大完全性重建临床一例
Q4 Medicine Pub Date : 2022-09-26 DOI: 10.30702/ujcvs/22.30(03)/pb033-104108
V. Popov, V. Boukarim, O. Bolshak, Olena V. Khoroshkovata, O. Yuvchyk
Implementation of the principles of medical preparation, comprehensive reconstruction of the left heart in patients with atriomegaly and ventriculomegaly and combined mitral-tricuspid valve diseases leads to improvement of myocardial function and morphometric parameters of the left atrium (LA) and left ventricle (LV). Case description. Patient R., male, 67 years old, underwent examination and treatment from April 22 to May 25, 2021 at the department of surgical treatment of acquired heart diseases of the National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine with the diagnosis of stage IV mitral regurgitation, stage IV tricuspid insufficiency, high grade pulmonary hypertension, permanent atrial fibrillation (lasting 10 years since 2011), IIB heart failure with reduced left ventricular ejection fraction (LVEF), secondary hypothyroidism (state of drug subcompensation). Upon admission, the patient was in a state of circulatory decompensation, which required long-term medical preparation for the operation. After his condition was improved, the patient underwent surgery: mitral valve replacement with complete preservation of the valve apparatus, triangular plasty of LA, tricuspid valve plasty with the imposition of a support ring and resection of the right atrium. There were no complications during the intraoperative period. The postoperative period was characterized by symptoms of hyperbilirubinemia, increased exudation from drainages on the first day after surgery. After appropriate treatment, the patient’s condition was stabilized. The patient was discharged on the 13th day after surgery with improvement. Conclusion. Given the initial severe condition of the patient with advanced heart disease with reduced LVEF, left atriomegaly 9.5x12.3 cm, high grade pulmonary hypertension (peak systolic pressure = 70 mm Hg) and comorbidities, comprehensive reconstruction of the left heart with atriomegaly and ventriculomegaly leads to improvement of functional state of the myocardium and morphometric parameters of LA and LV.
心房和心室肿大合并二尖瓣和三尖瓣合并病变患者实施医学准备、左心全面重建原则,使心肌功能和左心房、左心室形态学参数得到改善。案例描述。患者R,男,67岁,于2021年4月22日至5月25日在乌克兰国家医学科学院国立阿莫索夫心血管外科研究所获得性心脏病外科治疗科接受检查和治疗,诊断为IV期二尖瓣反流,IV期三尖瓣不全,重度肺动脉高压,永久性房颤(2011年至今,持续10年)。IIB心力衰竭伴左室射血分数(LVEF)降低,继发性甲状腺功能减退(药物亚代偿状态)。入院时,患者处于循环失代偿状态,需要为手术做长期的医疗准备。在病情好转后,患者接受了手术:二尖瓣置换术,完全保留瓣膜装置,LA三角形成形术,三尖瓣成形术,施加支撑环并切除右心房。术中无并发症发生。术后以高胆红素血症症状为特征,术后第一天引流液渗出物增多。经适当治疗,患者病情稳定。患者术后13天出院,病情好转。结论。考虑到晚期心脏病患者初始病情严重,LVEF降低,左心房扩大9.5x12.3 cm,高级别肺动脉高压(收缩压峰值= 70 mm Hg)及合并症,综合重建左心并心房和心室扩大,可改善心肌功能状态及左室、左室形态学参数。
{"title":"Complete Reconstruction of the Left Heart with Atriomegaly and Ventriculomegaly: Clinical Case","authors":"V. Popov, V. Boukarim, O. Bolshak, Olena V. Khoroshkovata, O. Yuvchyk","doi":"10.30702/ujcvs/22.30(03)/pb033-104108","DOIUrl":"https://doi.org/10.30702/ujcvs/22.30(03)/pb033-104108","url":null,"abstract":"Implementation of the principles of medical preparation, comprehensive reconstruction of the left heart in patients with atriomegaly and ventriculomegaly and combined mitral-tricuspid valve diseases leads to improvement of myocardial function and morphometric parameters of the left atrium (LA) and left ventricle (LV). \u0000Case description. Patient R., male, 67 years old, underwent examination and treatment from April 22 to May 25, 2021 at the department of surgical treatment of acquired heart diseases of the National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine with the diagnosis of stage IV mitral regurgitation, stage IV tricuspid insufficiency, high grade pulmonary hypertension, permanent atrial fibrillation (lasting 10 years since 2011), IIB heart failure with reduced left ventricular ejection fraction (LVEF), secondary hypothyroidism (state of drug subcompensation). Upon admission, the patient was in a state of circulatory decompensation, which required long-term medical preparation for the operation. After his condition was improved, the patient underwent surgery: mitral valve replacement with complete preservation of the valve apparatus, triangular plasty of LA, tricuspid valve plasty with the imposition of a support ring and resection of the right atrium. There were no complications during the intraoperative period. The postoperative period was characterized by symptoms of hyperbilirubinemia, increased exudation from drainages on the first day after surgery. After appropriate treatment, the patient’s condition was stabilized. The patient was discharged on the 13th day after surgery with improvement. \u0000Conclusion. Given the initial severe condition of the patient with advanced heart disease with reduced LVEF, left atriomegaly 9.5x12.3 cm, high grade pulmonary hypertension (peak systolic pressure = 70 mm Hg) and comorbidities, comprehensive reconstruction of the left heart with atriomegaly and ventriculomegaly leads to improvement of functional state of the myocardium and morphometric parameters of LA and LV.","PeriodicalId":33680,"journal":{"name":"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45219890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Clinical Effect of Dapagliflozin in Patients with Angiographically Confirmed Coronary Artery Disease and Concomitant Type 2 Diabetes Mellitus 达格列嗪治疗经血管造影证实的冠心病合并2型糖尿病患者的临床疗效
Q4 Medicine Pub Date : 2022-09-26 DOI: 10.30702/ujcvs/22.30(03)/dm031-3543
Ya.Yu. Dzhun, Y. Marushko, Ya.A. Saienko, N. Rudenko, B. Mankovsky
Nowadays treatment of patients with coronary artery disease (CAD) and concomitant type 2 diabetes mellitus (DM) needs further study. The aim. Evaluation of the clinical effect and glycemic variability of dapagliflozin in patients with angiographically confirmed CAD and concomitant type 2 DM. Materials and methods. The study involved 47 patients with angiographically confirmed CAD. The patients underwent laboratory blood tests, electrocardiography, echocardiography, continuous glucose monitoring and percutaneous coronary intervention (PCI). Depending on the usage of dapagliflozin 10 mg, the patients were divided into 2 groups: group I (+SGLT2i, n = 24) and group II (–SGLT2i, n = 23). The average follow-up period was 16 months. Results. Distribution of the examined patients by age, anthropometric characteristics, duration of DM, functional state of the heart and kidneys, smoking, the presence of acute cardiovascular events and previous PCI showed no statistically significant difference. In patients of group I, on the background of taking SGLT2i, a decrease in body mass index and improved glycemic profile were revealed. Patients in group II were more likely to have complaints of angina (4 [17.3%] vs 1 [4.3%], p>0.05); repeated coronary angiography in this group was significantly more likely to reveal progression to atherosclerotic CAD (4 [17.3%], p<0.05) which required re-revascularization. No fatalities were detected during the follow-up. Conclusion. Dapagliflozin has improved glycemic and lipid profile of the blood and long-term prognosis after PCI. Adding this drug to the treatment reduces the clinical progression of CAD, the need for re-hospitalization and cardiac revascularization.
目前,冠状动脉疾病(CAD)合并2型糖尿病(DM)的治疗方法有待进一步研究。的目标。评价达格列净对冠心病合并2型糖尿病患者的临床疗效和血糖变异性。材料和方法。该研究纳入了47例经血管造影证实的冠心病患者。患者接受了实验室血液检查、心电图、超声心动图、连续血糖监测和经皮冠状动脉介入治疗(PCI)。根据达格列净10mg的使用情况,将患者分为2组:I组(+SGLT2i, n = 24)和II组(-SGLT2i, n = 23)。平均随访时间为16个月。结果。年龄、人体测量特征、糖尿病病程、心肾功能状态、吸烟情况、有无急性心血管事件及既往PCI的分布差异无统计学意义。在I组患者中,在服用SGLT2i的背景下,体重指数下降,血糖谱改善。II组患者出现心绞痛主诉的可能性更大(4例[17.3%]vs 1例[4.3%],p < 0.05);该组反复冠状动脉造影更有可能显示动脉粥样硬化性CAD进展(4例[17.3%],p<0.05),需要再血运重建。随访期间未发现死亡病例。结论。达格列净改善了PCI术后的血糖和血脂状况和长期预后。在治疗中加入该药可减少CAD的临床进展、再次住院和心脏血运重建术的需要。
{"title":"The Clinical Effect of Dapagliflozin in Patients with Angiographically Confirmed Coronary Artery Disease and Concomitant Type 2 Diabetes Mellitus","authors":"Ya.Yu. Dzhun, Y. Marushko, Ya.A. Saienko, N. Rudenko, B. Mankovsky","doi":"10.30702/ujcvs/22.30(03)/dm031-3543","DOIUrl":"https://doi.org/10.30702/ujcvs/22.30(03)/dm031-3543","url":null,"abstract":"Nowadays treatment of patients with coronary artery disease (CAD) and concomitant type 2 diabetes mellitus (DM) needs further study. \u0000The aim. Evaluation of the clinical effect and glycemic variability of dapagliflozin in patients with angiographically confirmed CAD and concomitant type 2 DM. \u0000Materials and methods. The study involved 47 patients with angiographically confirmed CAD. The patients underwent laboratory blood tests, electrocardiography, echocardiography, continuous glucose monitoring and percutaneous coronary intervention (PCI). Depending on the usage of dapagliflozin 10 mg, the patients were divided into 2 groups: group I (+SGLT2i, n = 24) and group II (–SGLT2i, n = 23). The average follow-up period was 16 months. \u0000Results. Distribution of the examined patients by age, anthropometric characteristics, duration of DM, functional state of the heart and kidneys, smoking, the presence of acute cardiovascular events and previous PCI showed no statistically significant difference. In patients of group I, on the background of taking SGLT2i, a decrease in body mass index and improved glycemic profile were revealed. Patients in group II were more likely to have complaints of angina (4 [17.3%] vs 1 [4.3%], p>0.05); repeated coronary angiography in this group was significantly more likely to reveal progression to atherosclerotic CAD (4 [17.3%], p<0.05) which required re-revascularization. No fatalities were detected during the follow-up. \u0000Conclusion. Dapagliflozin has improved glycemic and lipid profile of the blood and long-term prognosis after PCI. Adding this drug to the treatment reduces the clinical progression of CAD, the need for re-hospitalization and cardiac revascularization.","PeriodicalId":33680,"journal":{"name":"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44301707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the Methods of Surgical Treatment of Complex Congenital Heart Defects Combined with Right Ventricular Hypoplasia 复杂先天性心脏病合并右心室发育不全的手术治疗方法比较
Q4 Medicine Pub Date : 2022-09-26 DOI: 10.30702/ujcvs/22.30(03)/dt044-6875
I. Dziuryi, I. Truba, Vasyl V. Fylypchuk, I. Perepeka, V. Lazoryshynets
Surgical treatment of complex congenital heart defects (CHD) in patients who cannot undergo radical correction due to pronounced hypoplasia or dysfunction of the right ventricle (RV) remains one of the most urgent problems in pediatric cardiac surgery. In 1989, Billingsley et al. first reported the addition of bidirectional cavopulmonary anastomosis to definitive biventricular repair in patients with RV hypoplasia, pulmonary artery atresia, and intact interventricular septum in four patients, and introduced the term one and half ventricle repair (1.5VR). The method of 1.5VR consists of bidirectional cavopulmonary anastomosis, which reduces the volume load on the RV, in addition to the complete repair of other CHDs. The aim. To assess perioperative characteristics of patients, immediate and long-term results after surgical correction of complex CHD through the method of 1.5VR. Materials and methods. In the period from 1996 to 2022, surgical correction was performed in 33 patients with complex CHD combined with hypoplasia and/or dysfunction of the RV at the National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine. There were 21 male patients (64%) and 12 female patients (36%). The mean age of the patients at the time of surgery was 57.9 months. Me = 34 [3.5; 312] months. The main method of diagnosis in determining the defect and assessing the immediate and long-term results was echocardiographic examination and probing of the heart cavities, which made it possible to assess the morphology, kinetics of the heart structures, and hemodynamic state. Depending on the selected tactics of surgical treatment, all the patients were divided into two groups: group І (n=21) with patients operated through the method of 1.5VR, and group ІІ (n = 12) including those operated through the single ventricle pathway. Results. In the early postoperative period, there were 3 (9%) deaths in both groups: one (4.7%) death in group I, and 2 (16%) deaths among patients of group II. In all the deceased patients, the cause of death was acute heart failure, which subsequently led to multiple organ failure. In one patient of the group II, in addition to heart failure, acute cerebrovascular accident occurred. In the group I, the average indicator of systemic saturation (92±6.2%) at discharge from the hospital was higher, than that in group II (87±4.7%). Average duration of mechanical ventilation (10±7.3 vs. 15±7.8 hours), total exudation (65±34 vs. 88.8±39.9 hours), total duration of sympathomimetic support (71±27.5 vs. 108±75.5 hours) and its doses (4.8±2 vs. 6.5±3.8 μkg/kg/hour) were significantly lower in the group I, therefore, the patients of the group II stayed almost twice as long in the intensive care department (146±56 vs. 96±49.8 hours), although the total length of hospital stay did not differ significantly (25±3.8 vs. 26±12.3 days). An uncomplicated course of the early postoperative period was observed in 15 (46%) pa
复杂先天性心脏缺陷(CHD)患者由于右心室(RV)明显发育不全或功能障碍而无法根治性矫正,手术治疗仍然是儿科心脏外科最紧迫的问题之一。1989年,Billingsley等人首次报道了4例右心室发育不全、肺动脉闭锁、室间隔完整的患者,在确定双心室修复的基础上,增加了双向腔隙肺吻合,并引入了一个半心室修复(1.5VR)一词。1.5VR的方法包括双向腔隙肺吻合术,减少了右心室的体积负荷,同时可以完全修复其他冠心病。的目标。目的:评价1.5VR法矫正复杂冠心病患者围手术期特点、近期及远期疗效。材料和方法。1996年至2022年期间,在乌克兰国家医学科学院国立阿莫索夫心血管外科研究所对33例合并右心室发育不全和/或功能障碍的复杂冠心病患者进行了手术矫正。男性21例(64%),女性12例(36%)。手术时患者的平均年龄为57.9个月。Me = 34 [3.5;312个月。超声心动图检查和心腔探查是确定缺陷和评估近期和长期结果的主要诊断方法,可以评估心脏结构的形态、动力学和血流动力学状态。根据所选择的手术治疗策略,将所有患者分为两组:І组(n=21)采用1.5VR方式手术,ІІ组(n= 12)采用单心室径路手术。结果。术后早期,两组均有3例(9%)死亡:1组1例(4.7%)死亡,2组2例(16%)死亡。在所有死亡的患者中,死亡原因是急性心力衰竭,随后导致多器官衰竭。II组1例患者除心力衰竭外,还发生急性脑血管意外。ⅰ组患者出院时全身饱和度平均指标(92±6.2%)高于ⅱ组(87±4.7%)。平均机械通气时间(10±7.3小时比15±7.8小时)、总渗液时间(65±34小时比88.8±39.9小时)、总交感神经支持时间(71±27.5小时比108±75.5小时)及其剂量(4.8±2比6.5±3.8 μkg/kg/小时)均显著低于ⅰ组(146±56小时比96±49.8小时),因此,ⅱ组患者在重症监护室的停留时间几乎是ⅱ组的两倍(146±56小时比96±49.8小时)。虽然总住院时间没有显著差异(25±3.8天和26±12.3天)。15例(46%)患者术后早期病程不复杂。另有18例(54%)患者出现并发症:I组8例(24%)患者出现9例并发症,II组10例(30%)患者出现14例并发症。平均观察时间48±29.8个月,(6 ~ 190个月)。两组26例(79%)患者观察期内无死亡,4例(12%)患者失访。II组7例(58%)采用全腔静脉-肺吻合术(Fontan)。第一组17例患者(81%)的血液动力学指标显示长期效果良好,不需要其他干预。1组15例(20例中3例)右心房平均高压14±1.8 mmHg引起注意,下腔静脉和肝静脉扩张,5例(20%)上腔静脉平均高压16±2.7 mmHg。两组患者观察期内无移植生存率均为100%。结论:对于右心室解剖或功能状态介于双心室重建和单心室通路之间的儿童,1.5VR是姑息性Fontan策略的合理替代方案,具有良好的近期和远期效果。
{"title":"Comparison of the Methods of Surgical Treatment of Complex Congenital Heart Defects Combined with Right Ventricular Hypoplasia","authors":"I. Dziuryi, I. Truba, Vasyl V. Fylypchuk, I. Perepeka, V. Lazoryshynets","doi":"10.30702/ujcvs/22.30(03)/dt044-6875","DOIUrl":"https://doi.org/10.30702/ujcvs/22.30(03)/dt044-6875","url":null,"abstract":"Surgical treatment of complex congenital heart defects (CHD) in patients who cannot undergo radical correction due to pronounced hypoplasia or dysfunction of the right ventricle (RV) remains one of the most urgent problems in pediatric cardiac surgery. In 1989, Billingsley et al. first reported the addition of bidirectional cavopulmonary anastomosis to definitive biventricular repair in patients with RV hypoplasia, pulmonary artery atresia, and intact interventricular septum in four patients, and introduced the term one and half ventricle repair (1.5VR). The method of 1.5VR consists of bidirectional cavopulmonary anastomosis, which reduces the volume load on the RV, in addition to the complete repair of other CHDs. \u0000The aim. To assess perioperative characteristics of patients, immediate and long-term results after surgical correction of complex CHD through the method of 1.5VR. \u0000Materials and methods. In the period from 1996 to 2022, surgical correction was performed in 33 patients with complex CHD combined with hypoplasia and/or dysfunction of the RV at the National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine. There were 21 male patients (64%) and 12 female patients (36%). The mean age of the patients at the time of surgery was 57.9 months. Me = 34 [3.5; 312] months. The main method of diagnosis in determining the defect and assessing the immediate and long-term results was echocardiographic examination and probing of the heart cavities, which made it possible to assess the morphology, kinetics of the heart structures, and hemodynamic state. Depending on the selected tactics of surgical treatment, all the patients were divided into two groups: group І (n=21) with patients operated through the method of 1.5VR, and group ІІ (n = 12) including those operated through the single ventricle pathway. \u0000Results. In the early postoperative period, there were 3 (9%) deaths in both groups: one (4.7%) death in group I, and 2 (16%) deaths among patients of group II. In all the deceased patients, the cause of death was acute heart failure, which subsequently led to multiple organ failure. In one patient of the group II, in addition to heart failure, acute cerebrovascular accident occurred. In the group I, the average indicator of systemic saturation (92±6.2%) at discharge from the hospital was higher, than that in group II (87±4.7%). Average duration of mechanical ventilation (10±7.3 vs. 15±7.8 hours), total exudation (65±34 vs. 88.8±39.9 hours), total duration of sympathomimetic support (71±27.5 vs. 108±75.5 hours) and its doses (4.8±2 vs. 6.5±3.8 μkg/kg/hour) were significantly lower in the group I, therefore, the patients of the group II stayed almost twice as long in the intensive care department (146±56 vs. 96±49.8 hours), although the total length of hospital stay did not differ significantly (25±3.8 vs. 26±12.3 days). An uncomplicated course of the early postoperative period was observed in 15 (46%) pa","PeriodicalId":33680,"journal":{"name":"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46545912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brain Protection in Patients with Aortic Dissection and Coronary Artery Disease 主动脉夹层和冠状动脉疾病患者的脑保护
Q4 Medicine Pub Date : 2022-09-26 DOI: 10.30702/ujcvs/22.30(03)/zhk038-9397
I. Zhekov, V. Kravchenko, Oleh I. Sarhosh, Genadii A. Zinchenko, A. Rudenko
The aim. To compare the effectiveness of methods of protecting the brain and visceral organs during operations for aortic aneurysms combined with coronary artery lesions. Materials and methods. In the period from 2012 to 2020, 23 patients with Stanford type A and non-A non-B aortic dissection with damage to the coronary arteries were operated at the National Amosov Institute of Cardiovascular Surgery of the NAMS of Ukraine using the brain protection techniques. Out of 23 surgical interventions, 16 were performed for Stanford type A acute aortic dissection, 3 for Stanford type A chronic aortic dissection, 1 for Stanford type A subacute aortic dissection, and 3 for Stanford non-A non-B aortic dissection. The main causes of aortic dissection were hypertension (16 patients), Marfan syndrome (3 patients), bicuspid aortic valve (4 patients). Results. The most threatening postoperative complication in this group of patients is neurological damage, which was observed in 4 (17%) patients after surgery, with gradual recovery of brain function. Also, the complications observed were respiratory failure in 3 (13%) patients, which required long-term artificial ventilation (more than 72 hours), and multiple organ failure in 1 (4.3%) patient, which caused a fatal outcome.Complications such as kidney and liver failure were not observed (most likely due to the small sample size). Heart failure was not noted as well. Hospital mortality was 4.3% (1 fatal case). In our study, among the entire group of operated patients, symptoms of neurological damage occurred in 4 (17.4%) patients, hemorrhagic stroke was present in 1 (4.3%) patient with a complicated medical history, 2 (8.6%) patients had hemiparesis and in 1 case (4.3%) there were cognitive disorders. Conclusions. Comparing brain protection techniques, taking into account the prolongation of aortic clamping time due to coronary artery shunting compared to isolated aortic dissection, it can be concluded that longer duration of selective brain perfusion (retrograde or antegrade) or duration of circulatory arrest more often lead to postoperative complications, namely neurological lesions. On the other hand, the small number of observations does not make it possible to fully assess the impact of each of the techniques. Further follow-up with a larger sample will provide opportunities for a more complete evaluation of brain protection techniques in operations for dissecting aortic aneurysms and coronary artery lesions.
的目标。目的比较主动脉瘤合并冠状动脉病变手术中脑脏器保护方法的有效性。材料和方法。2012年至2020年,在乌克兰NAMS国家阿莫索夫心血管外科研究所采用脑保护技术对23例冠状动脉损伤的Stanford A型和非A型非b型主动脉夹层患者进行了手术。在23例手术干预中,有16例是针对斯坦福A型急性主动脉夹层,3例是针对斯坦福A型慢性主动脉夹层,1例是针对斯坦福A型亚急性主动脉夹层,3例是针对斯坦福非A非b型主动脉夹层。导致主动脉夹层的主要原因为高血压(16例)、马凡氏综合征(3例)、二尖瓣主动脉瓣(4例)。结果。本组患者术后最严重的并发症是神经损伤,术后4例(17%)患者出现神经损伤,脑功能逐渐恢复。此外,观察到的并发症有3例(13%)患者呼吸衰竭,需要长期人工通气(超过72小时),1例(4.3%)患者多器官衰竭,导致死亡。未观察到肾脏和肝脏衰竭等并发症(很可能是由于样本量小)。心脏衰竭也没有被注意到。住院死亡率为4.3%(1例死亡)。本组手术患者中,4例(17.4%)患者出现神经损伤症状,1例(4.3%)患者有复杂病史,2例(8.6%)患者有偏瘫,1例(4.3%)患者有认知障碍。结论。对比脑保护技术,考虑到冠状动脉分流导致的主动脉夹持时间比孤立的主动脉夹层延长,可以得出结论,更长的选择性脑灌注时间(逆行或顺行)或循环停搏时间更容易导致术后并发症,即神经系统病变。另一方面,由于观测的数量很少,因此不可能充分评估每种技术的影响。对更大样本的进一步随访将为更全面地评估夹层动脉瘤和冠状动脉病变手术中的脑保护技术提供机会。
{"title":"Brain Protection in Patients with Aortic Dissection and Coronary Artery Disease","authors":"I. Zhekov, V. Kravchenko, Oleh I. Sarhosh, Genadii A. Zinchenko, A. Rudenko","doi":"10.30702/ujcvs/22.30(03)/zhk038-9397","DOIUrl":"https://doi.org/10.30702/ujcvs/22.30(03)/zhk038-9397","url":null,"abstract":"The aim. To compare the effectiveness of methods of protecting the brain and visceral organs during operations for aortic aneurysms combined with coronary artery lesions. \u0000Materials and methods. In the period from 2012 to 2020, 23 patients with Stanford type A and non-A non-B aortic dissection with damage to the coronary arteries were operated at the National Amosov Institute of Cardiovascular Surgery of the NAMS of Ukraine using the brain protection techniques. Out of 23 surgical interventions, 16 were performed for Stanford type A acute aortic dissection, 3 for Stanford type A chronic aortic dissection, 1 for Stanford type A subacute aortic dissection, and 3 for Stanford non-A non-B aortic dissection. The main causes of aortic dissection were hypertension (16 patients), Marfan syndrome (3 patients), bicuspid aortic valve (4 patients). \u0000Results. The most threatening postoperative complication in this group of patients is neurological damage, which was observed in 4 (17%) patients after surgery, with gradual recovery of brain function. Also, the complications observed were respiratory failure in 3 (13%) patients, which required long-term artificial ventilation (more than 72 hours), and multiple organ failure in 1 (4.3%) patient, which caused a fatal outcome.Complications such as kidney and liver failure were not observed (most likely due to the small sample size). Heart failure was not noted as well. Hospital mortality was 4.3% (1 fatal case). In our study, among the entire group of operated patients, symptoms of neurological damage occurred in 4 (17.4%) patients, hemorrhagic stroke was present in 1 (4.3%) patient with a complicated medical history, 2 (8.6%) patients had hemiparesis and in 1 case (4.3%) there were cognitive disorders. \u0000Conclusions. Comparing brain protection techniques, taking into account the prolongation of aortic clamping time due to coronary artery shunting compared to isolated aortic dissection, it can be concluded that longer duration of selective brain perfusion (retrograde or antegrade) or duration of circulatory arrest more often lead to postoperative complications, namely neurological lesions. \u0000On the other hand, the small number of observations does not make it possible to fully assess the impact of each of the techniques. Further follow-up with a larger sample will provide opportunities for a more complete evaluation of brain protection techniques in operations for dissecting aortic aneurysms and coronary artery lesions.","PeriodicalId":33680,"journal":{"name":"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42971751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prenatal Diagnosis of Chromosome 22q11.21 Microduplication Syndrome in a Fetus with Congenital Malformation of the Cardiovascular System: Case Report 先天性心血管系统畸形胎儿22q11.21染色体微重复综合征的产前诊断:病例报告
Q4 Medicine Pub Date : 2022-09-26 DOI: 10.30702/ujcvs/22.30(03)/gd037-98103
V. Galagan, Y. Dudierina, A. Pavlova
A clinical case of microduplication of chromosome 22q11.21 in a fetus with a malformation of the cardiovascular system (vascular ring) is presented. This anatomical variant of the vascular ring is extremely rare and is formed by the pathological circumflex retroesophageal left-sided cervical aortic arch with the left arterial ductus arteriosus. The anatomical features of the circumflex cervical aortic arch are the left-sided pathological curved aortic arch in combination with the right-sided descending aorta. This vascular pathology can cause compression of the trachea and esophagus. This variant of the vascular ring is extremely unfavorable for surgical correction. Chromosome 22q11.21 microduplication syndrome is associated with the clinical presentation of “cat eye syndrome”. The clinical case description shows unique data from instrumental and genetic studies. All stages of examination of a pregnant woman from primary to tertiary medical care are described. The features and importance of a multidisciplinary approach are also presented. Every case of congenital heart defect in fetus, confirmed by echocardiographic method in a specialized institution, requires medical and genetic counseling. Using of the highly sensitive specific molecular cytogenetic method, comparative genomic hybridization, in prenatal diagnosis allows for timely diagnosis of microstructural disorders of chromosomes in fetus. Follow-up of a pregnant woman with congenital heart defect in the fetus requires a multidisciplinary approach not only to improve diagnosis and treatment, but also to calculate genetic risk.
本文报告了一例心血管系统(血管环)畸形胎儿染色体22q11.21微重复的临床病例。这种血管环的解剖变异极为罕见,是由病理性旋食管后左侧颈主动脉弓和左动脉导管形成的。旋颈主动脉弓的解剖特征是左侧病理性弯曲主动脉弓与右侧降主动脉结合。这种血管病变可导致气管和食道受压。血管环的这种变体对于外科矫正是极其不利的。染色体22q11.21微重复综合征与“猫眼综合征”的临床表现有关。临床病例描述显示了来自仪器和遗传学研究的独特数据。描述了孕妇从初级到三级医疗保健的所有检查阶段。还介绍了多学科方法的特点和重要性。在专门机构通过超声心动图方法确认的每一例胎儿先天性心脏缺陷都需要医学和遗传咨询。在产前诊断中使用高灵敏度的特异性分子细胞遗传学方法,即比较基因组杂交,可以及时诊断胎儿染色体的微观结构紊乱。胎儿先天性心脏缺陷孕妇的随访需要多学科的方法,不仅要改进诊断和治疗,还要计算遗传风险。
{"title":"Prenatal Diagnosis of Chromosome 22q11.21 Microduplication Syndrome in a Fetus with Congenital Malformation of the Cardiovascular System: Case Report","authors":"V. Galagan, Y. Dudierina, A. Pavlova","doi":"10.30702/ujcvs/22.30(03)/gd037-98103","DOIUrl":"https://doi.org/10.30702/ujcvs/22.30(03)/gd037-98103","url":null,"abstract":"A clinical case of microduplication of chromosome 22q11.21 in a fetus with a malformation of the cardiovascular system (vascular ring) is presented. This anatomical variant of the vascular ring is extremely rare and is formed by the pathological circumflex retroesophageal left-sided cervical aortic arch with the left arterial ductus arteriosus. The anatomical features of the circumflex cervical aortic arch are the left-sided pathological curved aortic arch in combination with the right-sided descending aorta. This vascular pathology can cause compression of the trachea and esophagus. This variant of the vascular ring is extremely unfavorable for surgical correction. Chromosome 22q11.21 microduplication syndrome is associated with the clinical presentation of “cat eye syndrome”. The clinical case description shows unique data from instrumental and genetic studies. All stages of examination of a pregnant woman from primary to tertiary medical care are described. The features and importance of a multidisciplinary approach are also presented. \u0000Every case of congenital heart defect in fetus, confirmed by echocardiographic method in a specialized institution, requires medical and genetic counseling. Using of the highly sensitive specific molecular cytogenetic method, comparative genomic hybridization, in prenatal diagnosis allows for timely diagnosis of microstructural disorders of chromosomes in fetus. Follow-up of a pregnant woman with congenital heart defect in the fetus requires a multidisciplinary approach not only to improve diagnosis and treatment, but also to calculate genetic risk.","PeriodicalId":33680,"journal":{"name":"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44959650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Features and Selection of Hypolipidemic Therapy in Patients with Coronary Artery Disease with “Possible” Familial Hypercholesterolemia “可能的”家族性高胆固醇血症冠状动脉病患者的诊断特点及降糖治疗的选择
Q4 Medicine Pub Date : 2022-09-26 DOI: 10.30702/ujcvs/22.30(03)/mt041-5059
O. Mitchenko, K. Timokhova, N. Chulaievska
The aim. To optimize the diagnostic algorithm for patients with true “possible” familial hypercholesterolemia (FH) and differential diagnosis with hypercholesterolemia on the background of comorbid endocrinopathies for selection of optimal hypolipidemic therapy. Materials and methods. We examined 130 patients with hypercholesterolemia and comorbid pathology (type 2 diabetes mellitus, hypothyroidism, obesity grade II-III). In each group, subgroups with low-density lipoproteins (LDL) ≥5 mmol/l were selected and followed up on the background of maximum tolerated doses of statins in combination with therapy aimed to compensate comorbid pathology. The control group consisted of 20 patients with verified FH. Results and discussion. Combined dyslipidemia was detected in groups 1 and 3, pure hypercholesterolemia in group 2. Direct correlations between lipid profile and comorbid pathology characteristics were revealed. Patients of the subgroups with “possible” FH had higher atherogenicity of the lipid profile associated with comorbid pathology destabilization and high percentage of atherosclerosis of carotid and coronary arteries. According to the results of the follow-up, it was established that statin therapy and comorbid pathology compensation led to the achievement of target levels of LDL (group 3) or a reduction of LDL by 50% (group 1, 2). In patients of the control group, statin therapy with maximally tolerated doses did not show such results. Conclusions. The cohort of patients defined as having “possible” FH is heterogeneous and may include patients with secondary dyslipidemia on the background of comorbid pathology destabilization, timely verification and treatment of which contributes to achieving the goals of lipid-lowering therapy. Taking into account that only obese patients reached the target level of LDL <1.8 mmol/l, combined lipid-lowering therapy is recommended for patients with hypothyroidism and diabetes. Refractoriness to statin therapy in patients with verified “possible” FH emphasizes the need for combined lipid-lowering therapy (ezetimibe, PCSK9 inhibitors).
的目标。优化真“可能”家族性高胆固醇血症(FH)患者的诊断算法,并在合并内分泌疾病的背景下鉴别诊断为高胆固醇血症,以选择最佳的降血脂治疗方案。材料和方法。我们检查了130例伴有高胆固醇血症和合并症的患者(2型糖尿病、甲状腺功能减退、II-III级肥胖)。在每组中,选择低密度脂蛋白(LDL)≥5 mmol/l的亚组,并在他汀类药物的最大耐受剂量与旨在补偿共病病理的治疗的背景下进行随访。对照组为确诊FH患者20例。结果和讨论。1、3组合并血脂异常,2组单纯高胆固醇血症。脂质谱与共病病理特征之间的直接相关性被揭示。“可能”FH亚组患者的脂质谱具有较高的动脉粥样硬化性,与共病病理不稳定和颈动脉和冠状动脉粥样硬化的高比例相关。根据随访结果,可以确定他汀类药物治疗和共病病理补偿导致LDL达到目标水平(第3组)或LDL降低50%(第1,2组)。在对照组患者中,最大耐受剂量的他汀类药物治疗没有显示出这样的结果。结论。被定义为“可能”FH的患者队列是异质性的,可能包括在共病病理不稳定背景下的继发性血脂异常患者,及时的验证和治疗有助于实现降脂治疗的目标。考虑到只有肥胖患者达到LDL <1.8 mmol/l的目标水平,建议甲状腺功能减退合并糖尿病患者联合降脂治疗。证实“可能的”FH患者对他汀类药物治疗的难治性强调了联合降脂治疗的必要性(依折麦布、PCSK9抑制剂)。
{"title":"Diagnostic Features and Selection of Hypolipidemic Therapy in Patients with Coronary Artery Disease with “Possible” Familial Hypercholesterolemia","authors":"O. Mitchenko, K. Timokhova, N. Chulaievska","doi":"10.30702/ujcvs/22.30(03)/mt041-5059","DOIUrl":"https://doi.org/10.30702/ujcvs/22.30(03)/mt041-5059","url":null,"abstract":"The aim. To optimize the diagnostic algorithm for patients with true “possible” familial hypercholesterolemia (FH) and differential diagnosis with hypercholesterolemia on the background of comorbid endocrinopathies for selection of optimal hypolipidemic therapy. \u0000Materials and methods. We examined 130 patients with hypercholesterolemia and comorbid pathology (type 2 diabetes mellitus, hypothyroidism, obesity grade II-III). In each group, subgroups with low-density lipoproteins (LDL) ≥5 mmol/l were selected and followed up on the background of maximum tolerated doses of statins in combination with therapy aimed to compensate comorbid pathology. The control group consisted of 20 patients with verified FH. \u0000Results and discussion. Combined dyslipidemia was detected in groups 1 and 3, pure hypercholesterolemia in group 2. Direct correlations between lipid profile and comorbid pathology characteristics were revealed. Patients of the subgroups with “possible” FH had higher atherogenicity of the lipid profile associated with comorbid pathology destabilization and high percentage of atherosclerosis of carotid and coronary arteries. According to the results of the follow-up, it was established that statin therapy and comorbid pathology compensation led to the achievement of target levels of LDL (group 3) or a reduction of LDL by 50% (group 1, 2). In patients of the control group, statin therapy with maximally tolerated doses did not show such results. \u0000Conclusions. The cohort of patients defined as having “possible” FH is heterogeneous and may include patients with secondary dyslipidemia on the background of comorbid pathology destabilization, timely verification and treatment of which contributes to achieving the goals of lipid-lowering therapy. Taking into account that only obese patients reached the target level of LDL <1.8 mmol/l, combined lipid-lowering therapy is recommended for patients with hypothyroidism and diabetes. Refractoriness to statin therapy in patients with verified “possible” FH emphasizes the need for combined lipid-lowering therapy (ezetimibe, PCSK9 inhibitors).","PeriodicalId":33680,"journal":{"name":"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46833775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intima-Media Thickness in Women with the History of Hypertensive Disorders of Pregnancy as a Risk Marker of the Occurrence of Cardiovascular Pathology in Advanced Reproductive and Perimenopausal Age 妊娠期高血压病史妇女的内膜-中膜厚度作为高龄育龄和围绝经期心血管疾病发生的危险标志
Q4 Medicine Pub Date : 2022-09-26 DOI: 10.30702/ujcvs/22.30(03)/dk032-2934
I. Davydova, I. G. Kryvorchuk, S. O. Siromakha, A. Lymanska, O. Kravets
Over the past twenty years, it has been proven that a history of preeclampsia entails a 4-fold risk of hypertension, coronary heart disease, stroke, type 2 diabetes, metabolic syndrome in the affected women at the age of 50-55 years. Evaluation of intima-media thickness (IMT) has diagnostic value for the assessment of remodeling and atherosclerotic vascular lesions and practical importance as a predictor of vascular accidents in patients with hypertension and atherosclerosis. The aim. To evaluate the IMT as an integrative biomarker of the occurrence of cardiovascular pathology in women with hypertensive disorders of pregnancy in their advanced reproductive age and in perimenopausal age. Materials and methods. We studied 51 women at the age of 48-55 years with the history of severe preeclampsia. The women were asked to fill out a questionnaire in which they indicated the presence of a diagnosis of hypertension, angina pectoris at the time of filling the questionnaire. The diagnosis of hypertension and angina attacks as well as other descriptions of the disease were taken away from the results of the women’s questionnaire. The investigators were not given copies of medical records. The control group consisted of 20 women aged 48-55 who had no history of preeclampsia or any other hypertensive disorders of pregnancy. Ultrasound imaging of the carotid arteries was performed according to the recommendations of the American Society of Echocardiography 2020 in women of both groups using SonoAce-8000 Ex scanner (Medison, South Korea) with a linear sensor UST5524 with a frequency of 7 MHz. IMT less than 0.7 mm was taken as a normal value for women. Results. It was revealed that almost every fourth woman at the age of 48-55 with the history of preeclampsia had signs of early angina attacks, and 30% suffered from hypertension. A threatening fact is that almost 6% of women at the age of 48-55 had the history of vascular thrombosis which is a manifestation of early atherosclerotic vascular lesions in the group of women with gestational hypertensive disorders. It is noteworthy that 21 (41.2%) women with the history of severe preeclampsia felt healthy and did not have any complaints. Importantly, among the women surveyed who had no health complaints, 66.6% (14 of 21) had IMT 0.85±0.01 mm. This accounts for about one third (27.4%) among 51 patients. This category of women is at high risk of developing cardiovascular complications in the future and require further monitoring and detailed examination. Thrombotic complications (dynamic bowel obstruction, mesenteric vascular thrombosis) were observed in 3 (5.9 %) women at the age of 48-55 with the history of severe preeclampsia. Conclusions. Examinations of women with the history of preeclampsia revealed that women at the age of 48-55 had increased IMT. It should be noted that increased IMT was found both in women with cardiovascular pathology (hypertension, thrombosis, angina attacks) and in asymptomatic patient
在过去的二十年里,已经证明先兆子痫病史会使50-55岁的女性患高血压、冠心病、中风、2型糖尿病和代谢综合征的风险增加4倍。内膜-中层厚度(IMT)的评估对评估重塑和动脉粥样硬化性血管病变具有诊断价值,并作为高血压和动脉粥样硬化患者血管意外的预测指标具有实际意义。目标。评估IMT作为一种综合性生物标志物在育龄晚期和围绝经期妊娠期高血压疾病妇女心血管病理发生率中的作用。材料和方法。我们研究了51名年龄在48-55岁之间有严重先兆子痫病史的女性。这些女性被要求填写一份问卷,在问卷中表明她们在填写问卷时被诊断为高血压、心绞痛。高血压和心绞痛发作的诊断以及对该疾病的其他描述从女性问卷的结果中删除。调查人员没有得到医疗记录的复印件。对照组由20名年龄在48-55岁之间的女性组成,她们没有先兆子痫或任何其他妊娠期高血压疾病的病史。根据美国超声心动图学会2020的建议,使用SonoAce-8000 Ex扫描仪(Medison,韩国)和频率为7MHz的线性传感器UST5524对两组女性进行颈动脉超声成像。IMT小于0.7mm被视为女性的正常值。后果研究表明,在48-55岁有先兆子痫病史的女性中,几乎每四分之一都有早期心绞痛发作的迹象,30%患有高血压。一个威胁性的事实是,在48-55岁的女性中,近6%的人有血管血栓形成史,这是妊娠期高血压疾病女性早期动脉粥样硬化性血管病变的表现。值得注意的是,21名(41.2%)有严重先兆子痫病史的女性感觉健康,没有任何抱怨。重要的是,在没有健康问题的受访女性中,66.6%(21人中有14人)的IMT为0.85±0.01 mm。这在51名患者中约占三分之一(27.4%)。这类女性未来患心血管并发症的风险很高,需要进一步监测和详细检查。在3名(5.9%)48-55岁有严重先兆子痫病史的女性中观察到血栓并发症(动态肠梗阻、肠系膜血管血栓形成)。结论。对有先兆子痫病史的女性进行的检查显示,48-55岁的女性IMT增加。值得注意的是,在有心血管疾病(高血压、血栓形成、心绞痛发作)的女性和无症状患者中都发现IMT增加。考虑到IMT增加是高血压患者靶器官损伤的特征之一,也是无症状患者心血管事件的标志,在有严重先兆子痫病史的女性的随访中纳入这项检查很重要,以避免早期严重心血管疾病的发展。
{"title":"Intima-Media Thickness in Women with the History of Hypertensive Disorders of Pregnancy as a Risk Marker of the Occurrence of Cardiovascular Pathology in Advanced Reproductive and Perimenopausal Age","authors":"I. Davydova, I. G. Kryvorchuk, S. O. Siromakha, A. Lymanska, O. Kravets","doi":"10.30702/ujcvs/22.30(03)/dk032-2934","DOIUrl":"https://doi.org/10.30702/ujcvs/22.30(03)/dk032-2934","url":null,"abstract":"Over the past twenty years, it has been proven that a history of preeclampsia entails a 4-fold risk of hypertension, coronary heart disease, stroke, type 2 diabetes, metabolic syndrome in the affected women at the age of 50-55 years. Evaluation of intima-media thickness (IMT) has diagnostic value for the assessment of remodeling and atherosclerotic vascular lesions and practical importance as a predictor of vascular accidents in patients with hypertension and atherosclerosis. \u0000The aim. To evaluate the IMT as an integrative biomarker of the occurrence of cardiovascular pathology in women with hypertensive disorders of pregnancy in their advanced reproductive age and in perimenopausal age. \u0000Materials and methods. We studied 51 women at the age of 48-55 years with the history of severe preeclampsia. The women were asked to fill out a questionnaire in which they indicated the presence of a diagnosis of hypertension, angina pectoris at the time of filling the questionnaire. The diagnosis of hypertension and angina attacks as well as other descriptions of the disease were taken away from the results of the women’s questionnaire. The investigators were not given copies of medical records. The control group consisted of 20 women aged 48-55 who had no history of preeclampsia or any other hypertensive disorders of pregnancy. Ultrasound imaging of the carotid arteries was performed according to the recommendations of the American Society of Echocardiography 2020 in women of both groups using SonoAce-8000 Ex scanner (Medison, South Korea) with a linear sensor UST5524 with a frequency of 7 MHz. IMT less than 0.7 mm was taken as a normal value for women. \u0000Results. It was revealed that almost every fourth woman at the age of 48-55 with the history of preeclampsia had signs of early angina attacks, and 30% suffered from hypertension. A threatening fact is that almost 6% of women at the age of 48-55 had the history of vascular thrombosis which is a manifestation of early atherosclerotic vascular lesions in the group of women with gestational hypertensive disorders. It is noteworthy that 21 (41.2%) women with the history of severe preeclampsia felt healthy and did not have any complaints. Importantly, among the women surveyed who had no health complaints, 66.6% (14 of 21) had IMT 0.85±0.01 mm. This accounts for about one third (27.4%) among 51 patients. This category of women is at high risk of developing cardiovascular complications in the future and require further monitoring and detailed examination. Thrombotic complications (dynamic bowel obstruction, mesenteric vascular thrombosis) were observed in 3 (5.9 %) women at the age of 48-55 with the history of severe preeclampsia. \u0000Conclusions. Examinations of women with the history of preeclampsia revealed that women at the age of 48-55 had increased IMT. It should be noted that increased IMT was found both in women with cardiovascular pathology (hypertension, thrombosis, angina attacks) and in asymptomatic patient","PeriodicalId":33680,"journal":{"name":"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46803465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of Bilateral Venous Thrombosis in a Patient with Aplasia of the Inferior Vena Cava 一例下腔静脉发育不全患者双侧静脉血栓形成的治疗
Q4 Medicine Pub Date : 2022-09-26 DOI: 10.30702/ujcvs/22.30(03)/kht036-109114
Y. Khrebtiy, D. V. Tsyhalko, Mykola O. Melnychuk
The aim. In the treatment of venous thromboembolism, a special place is occupied by patients with congenital anomalies of the development of the inferior vena cava (IVC). To date, only single cases of treatment of this pathology have been described in the literature. Studying the experience of treating patients with congenital anomalies of the IVC will allow to improve the results of treatment of this category of patients. Materials and methods. Patient B., a 36-year-old man, applied to the vascular surgery clinic of the Vinnytsia Regional Pyrohov Clinical Hospital in July 2010 with complaints of pain, swelling, cyanosis of both lower extremities, which bothered the patient for about 10 days. The patient had no history of venous insufficiency of both lower extremities. An objective examination revealed cyanosis and swelling of both lower extremities. A duplex scan of both lower extremities revealed hyperechoic iliofemoral thrombosis of both lower extremities. Aplasia of the IVC was diagnosed. The common iliac veins on both sides formed a collateral that flowed into the left renal vein. The infrarenal segment of the inferior vena cava was absent. Thrombosis spread from tibial to popliteal, femoral, iliac veins with venous collateral thrombosis up to the level of the left renal vein. The patient received enoxaparin at a dose of 1 mg per kg of body weight twice a day for 7 days with subsequent transition to warfarin under the control of international normalized ratio. Warfarin was prescribed from a starting dose of 5 mg with subsequent control of international normalized ratio in the range of 2.0-3.0. Venotonic and anti-inflammatory drugs were also prescribed. In combination with drug therapy, class 2 elastic compression stockings were recommended. After the treatment, the patient’s condition improved, swelling and cyanosis of both lower extremities regressed. Repeated duplex scanning at the discharge of the patient from the hospital after 7 days showed signs of initial recanalization of the affected venous segments and no progression of thrombosis. Conclusions. Thus, this clinical case showed that the use of anticoagulant therapy allows to obtain satisfactory results in the treatment of patients with congenital anomalies of the development of IVC, to avoid the development of pulmonary embolism and other life-threatening conditions. At the same time, such patients need regular follow-up examinations in order to adjust the treatment and prevent the development of IVC syndrome.
目标。在静脉血栓栓塞症的治疗中,先天性下腔静脉发育异常的患者占据了一个特殊的位置。到目前为止,文献中只描述了这种病理的单一治疗病例。研究IVC先天性异常患者的治疗经验将有助于提高这类患者的治疗效果。材料和方法。患者B,一名36岁的男子,于2010年7月向文尼齐亚Pyrohov地区临床医院的血管外科诊所提出申请,主诉双下肢疼痛、肿胀、发绀,困扰患者约10天。患者无双下肢静脉功能不全病史。客观检查显示双下肢发绀和肿胀。双下肢扫描显示双下肢髂股高回声血栓形成。诊断为IVC发育不全。两侧髂总静脉形成一个侧支,流入左肾静脉。下腔静脉肾下段缺失。血栓从胫骨蔓延至腘、股、髂静脉,静脉侧支血栓形成至左肾静脉。患者接受依诺肝素治疗,剂量为1 mg/kg体重,每天两次,持续7天,随后在国际标准化比率的控制下过渡到华法林。华法林的起始剂量为5mg,随后国际标准化比值控制在2.0-3.0范围内。还开了静脉和抗炎药。结合药物治疗,推荐使用2类弹性压缩袜。治疗后,患者病情好转,双下肢肿胀发绀症状消退。7天后患者出院时的重复双扫描显示,受影响的静脉段有初步再通的迹象,没有血栓形成的进展。结论。因此,该临床病例表明,使用抗凝治疗可以在治疗先天性IVC发育异常患者中获得令人满意的结果,避免发生肺栓塞和其他危及生命的情况。同时,这类患者需要定期随访检查,以调整治疗并防止IVC综合征的发展。
{"title":"Treatment of Bilateral Venous Thrombosis in a Patient with Aplasia of the Inferior Vena Cava","authors":"Y. Khrebtiy, D. V. Tsyhalko, Mykola O. Melnychuk","doi":"10.30702/ujcvs/22.30(03)/kht036-109114","DOIUrl":"https://doi.org/10.30702/ujcvs/22.30(03)/kht036-109114","url":null,"abstract":"The aim. In the treatment of venous thromboembolism, a special place is occupied by patients with congenital anomalies of the development of the inferior vena cava (IVC). To date, only single cases of treatment of this pathology have been described in the literature. Studying the experience of treating patients with congenital anomalies of the IVC will allow to improve the results of treatment of this category of patients. \u0000Materials and methods. Patient B., a 36-year-old man, applied to the vascular surgery clinic of the Vinnytsia Regional Pyrohov Clinical Hospital in July 2010 with complaints of pain, swelling, cyanosis of both lower extremities, which bothered the patient for about 10 days. The patient had no history of venous insufficiency of both lower extremities. \u0000An objective examination revealed cyanosis and swelling of both lower extremities. \u0000A duplex scan of both lower extremities revealed hyperechoic iliofemoral thrombosis of both lower extremities. Aplasia of the IVC was diagnosed. The common iliac veins on both sides formed a collateral that flowed into the left renal vein. The infrarenal segment of the inferior vena cava was absent. Thrombosis spread from tibial to popliteal, femoral, iliac veins with venous collateral thrombosis up to the level of the left renal vein. \u0000The patient received enoxaparin at a dose of 1 mg per kg of body weight twice a day for 7 days with subsequent transition to warfarin under the control of international normalized ratio. Warfarin was prescribed from a starting dose of 5 mg with subsequent control of international normalized ratio in the range of 2.0-3.0. Venotonic and anti-inflammatory drugs were also prescribed. In combination with drug therapy, class 2 elastic compression stockings were recommended. \u0000After the treatment, the patient’s condition improved, swelling and cyanosis of both lower extremities regressed. Repeated duplex scanning at the discharge of the patient from the hospital after 7 days showed signs of initial recanalization of the affected venous segments and no progression of thrombosis. \u0000Conclusions. Thus, this clinical case showed that the use of anticoagulant therapy allows to obtain satisfactory results in the treatment of patients with congenital anomalies of the development of IVC, to avoid the development of pulmonary embolism and other life-threatening conditions. At the same time, such patients need regular follow-up examinations in order to adjust the treatment and prevent the development of IVC syndrome.","PeriodicalId":33680,"journal":{"name":"Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45114036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ukrayins''kii zhurnal sertsevosudinnoyi khirurgiyi
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1